1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68A5780DCA33B1D89852571B50061EFDB
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/resources-required-to-manage-winning-commercial-operations-in-us-pharmaceutical-finance?opendocument
18
19opendocument
2018.212.222.217
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Financial Management

Resources Required to Manage Winning Commercial Operations in U.S. Pharmaceutical Finance

DB Image

ID: 4911


Features:

Metrics, Graphics, Detailed Process Map


Pages/Slides: 21


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

Non-members: Click here to sign-up for a complimentary tour of
"Resources Required to Manage Winning Commercial Operations in U.S. Pharmaceutical Finance"


Study Overview:
In today’s marketplace, pharmaceutical and biotechnology companies that operate in the U.S. market are experiencing intense pricing, political, regulatory and market pressures that create stress on the industry’s fundamental business model. Consequently, pharmaceutical and biotechnology companies – both large and small – are pressed to evaluate what’s the optimal level of human and capital investment in the commercial enterprise to ensure health and competitiveness. Due to increasing price and margin pressures, few companies can afford not to pay attention to how many people it staffs to critical functions.

This benchmarking study was designed to help provide pharmaceutical and biotech managers with insights about the levels of staff investment being channeled into their Finance functions across the industry. The benchmarks will permit senior executives and managers to assess their staffing and investment levels compared to the the industry as a whole.

Key Definitions:
The key function/activity areas examined include:

  • Accounting and Controlling Services: Corporate Accounting and Budgeting, Accounts Payable, Accounts Receivable and Tax.
  • Commercial Operations: Finance support for Marketing, Sales, Medical Affairs and Marketing Support Services.
  • Financial Planning and Analysis: Strategic Alliances, Business Performance Analysis, New Business Analysis and Finance support for Non-Marketing functions: G&A, HR, and Public Relations.

Key Topic Areas:
  • Budget Ranges for Finance Groups
  • Staffing Levels (FTE's)
  • Staff Allocation based on Functional Activities
  • Outsourcing Levels
  • Budget and FTE Efficiency Measures

Key Metrics:
  • Budget Ranges for Finance Groups ($US)
  • Staffing Levels (FTE’s)
  • Staff Allocation By Functional Activity Performed (Accounting and Controlling Services, Commercial Operations and Financial Planning And Analysis)
  • Outsourcing Levels (% Allocated To Ousourced Services)
  • Revenue per Finance FTE
  • Budget Employed Per FTE
  • Finance FTE Employed Per $100 Million In Sales Revenue
  • Finance Budget Expressed As A Percentage Of Sales

Data Customization:
Customized data analysis is available for an additional fee.

Methodology:
This research originated from a Best Practices, LLC research and consulting project. It was conducted for a pharmaceutical client and was based on surveys with executives and senior managers from pharmaceutical and biotech organizations.

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Chemical


Companies Profiled:
Roche; Biogen Idec; GlaxoSmithKline; Sigma-Tau; Berlex; Stiefel Laboratories; Solvay; Boehringer Ingelheim


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.